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mbandakamines B3 and B4, and related
5,80-coupled monomeric alkaloids, ikelacongolines
A–D, from a Congolese Ancistrocladus liana†
Jean-Pierre Mufusama,ab Doris Feineis,a Virima Mudogo,c Marcel Kaiser,de
Reto Brunde and Gerhard Bringmann *a
From the leaves of a botanically and phytochemically as yet unexplored Ancistrocladus liana discovered in the
rainforests of the Central region of the Democratic Republic of the Congo in the vicinity of the town of Ikela,
six new naphthylisoquinoline alkaloids were isolated, viz., two constitutionally unsymmetric dimers, the
mbandakamines B3 (3) and B4 (4), and four related 5,80-linked monomeric alkaloids, named ikelacongolines
A–D (5a, 5b, 6, and 7). The dimers 3 and 4 are structurally unusual quateraryls comprising two 5,80-coupled
monomers linked via a sterically strongly constrained 60,100-connection between their naphthalene units.
These compounds contain seven elements of chirality, four stereogenic centers and three consecutive
chiral axes. They were identiﬁed along with two known related compounds, the mbandakamines A (1) and
B2 (2), which had so far only been detected in two Ancistrocladus species indigenous to the Northwestern
Congo Basin. In addition, ﬁve known monomeric alkaloids, previously found in related Central African
Ancistrocladus species, were isolated from the here investigated Congolese liana, three of them belonging
to the subclass of 5,80-coupled naphthylisoquinoline alkaloids, whereas two compounds exhibited a less
frequently occurring 7,80-biaryl linkage. The stereostructures of the new alkaloids were established by
spectroscopic (in particular HRESIMS, 1D and 2D NMR), chemical (oxidative degradation), and chiroptical
(electronic circular dichroism) methods. The mbandakamines B3 (3) and B4 (4) displayed pronounced
activities in vitro against the malaria parasite Plasmodium falciparum and the pathogen of African sleeping
sickness, Trypanosoma brucei rhodesiense.Introduction
The evergreen rain forests and swamp regions in Central Africa,
in particular in the Democratic Republic of the Congo, are one
of the main centers of distribution of lianas belonging to the
Ancistrocladaceae plant family.1–3 Comprehensive data about
the natural diversity of the genus Ancistrocladus within the
Congo region, however, are still lacking.1,3 Recent eld trips in
combination with phylogenetic and phytochemicaly of Wu¨rzburg, Am Hubland, D-97074
mie.uni-wuerzburg.de
ersite´ de Kinshasa, B.P. 212, Kinshasa XI,
asa, B.P. 202, Kinshasa XI, Democratic
tute, Socinstrasse 57, CH-4002 Basel,
Basel, Switzerland
(ESI) available: Spectroscopic data
HSQC, HMBC, NOESY, and ROESY),
ounds 3, 4, 5a, 5b, 6, and 7. See DOI:
6investigations clearly suggested the presence of further, hith-
erto unrecognized taxa,3–11 along with the four botanically
acknowledged Ancistrocladus species,1,2,12,13 A. congolensis J.
Le´onard, A. likoko J. Le´onard, A. ealaensis J. Le´onard, and A.
ileboensis Heubl, Mudogo & G. Bringmann. The latter species
was discovered in the Southern Congo Basin, and described for
the rst time in 2010,12 whereas the three other Congolese taxa
were botanically acknowledged for the rst time in 1949.13
These three species are widely distributed in the North-Western
and North-Central region of the Democratic Republic of the
Congo.
It is all the more remarkable that phytochemical investiga-
tions on Central African Ancistrocladus plants have picked up
speed only quite recently, during the past decade,4–11,14–21
considering that intense isolation work on Asian as well as West
and East African taxa had started much earlier, leading to the
discovery of structurally unique mono- and dimeric naph-
thylisoquinoline alkaloids with promising antiparasitic and
antiviral activities.22–27 More recent phytochemical studies on
Ancistrocladus lianas from the Congo region, including all of the
four valid taxa14–21 mentioned above, but also botanically as yetThis journal is © The Royal Society of Chemistry 2019
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View Article Onlineunidentied plants,4–11 furnished a whole series of further
novel-type naphthylisoquinoline alkaloids, among them N,C-
coupled compounds9,10 and, in particular, dimeric representa-
tives with complex molecular architectures.4–8,14–16,18,21 Some of
these secondary metabolites attracted attention due to their
extraordinary antiplasmodial6,8,15,16 or antileishmanial10 activi-
ties or, according to their individual structures, to their strong
antiproliferative eﬀects against human leukemia,16,18,20 cervical
HeLa,7,21 or pancreatic cancer cells.7,9,17,19,21
Structurally most fascinating are the highly unsymmetric
mbandakamine-type dimers like e.g., mbandakamines A (1)4,16
and B2 (2)6 (Fig. 1), which were discovered in a botanically as yet
undescribed liana growing in the rainforests near the town of
Mbandaka in the Northwestern part of the Democratic Republic
of the Congo. The dimers 1 and 2 consist of two constitutionally
and stereochemically nearly identical 5,80-coupled monomeric
halves, which are linked via the sterically highly crowded 60,100-
positions of their naphthalene units. The central axis of 1 and 2
is thus located in one of the peri-positions of the ‘northwestern’
naphthalene portion, neighboring one of the outer axes in the
adjacent peri-position, which gives rise to a rotationally strongly
hindered central binaphthalene linkage.4,6,16 With the two outer
axes being chiral, too, 1 and 2 possess three consecutive ster-
eogenic axes, and, thus, together with four stereogenic centers
in their two tetrahydroisoquinoline subunits, a total of seven
elements of chirality.4,6,16 The two mbandakamines exerted
promising antiplasmodial and antitrypanosomal activities in
vitro,4,6 and mbandakamine A (1) was also found to display
strong cytotoxic activities against drug-sensitive (CCRF-CEM)
and multidrug-resistant (CEM/ADR5000) human leukemia
cells.16
Here, we describe the isolation and structural elucidation of
two new mbandakamine-type dimers, mbandakamines B3 (3)Fig. 1 Mbandakamine-type dimers and related 5,80-coupled monomer
Ancistrocladus liana: the two previously known4,6 mbandakamines A (1) an
isolated along with four new alkaloids, ikelacongolines A–D (5a, 5b, 6, a
This journal is © The Royal Society of Chemistry 2019and B4 (4) (Fig. 1), from the leaves of an as yet unidentied
Congolese Ancistrocladus liana. These two metabolites were
found to co-occur in the plant with the mbandakamines A (1)
and B2 (2). Such mbandakamine-type dimers have so far been
known to be present only in two Ancistrocladus species, viz., in
a botanically yet undescribed liana (three representatives)4,6 and
in A. ealaensis (four examples).16 Both plants grow in the
Mbandaka region.
Furthermore, we report on the identication of four new
monomeric 5,80-coupled naphthyltetrahydroisoquinolines,
named ikelacongolines A–D (5a, 5b, 6, and 7) (Fig. 1), in the
leaves of this undescribed Central Congolese Ancistrocladus
liana, along with three known and likewise 5,80-linked alkaloids
previously detected in the two Central African species A. con-
golensis and A. likoko, ancistrocongoline C (8)28 and the ancis-
trolikokines C (9)29 and F2 (10)17 (Fig. 2). In addition, two
naphthylisoquinoline alkaloids with a rare 7,80-linkage, the
ealamines A (11) and G (12)30 (Fig. 2), which had been isolated
for the rst time from the twigs and leaves of A. ealaensis only
recently, have now been found to be part of the metabolite
pattern of the here investigated liana.
As part of our ongoing studies on the antiparasitic potential
of naphthylisoquinoline alkaloids, the mbandakamines B3 (3)
and B4 (4) and the ikelacongolines A–C (5a, 5b, and 6) were
tested against the pathogens causing malaria tropica, leish-
maniasis, Chagas' disease, and African sleeping sickness.
Results and discussion
Isolation and structural elucidation of mono- and dimeric
naphthylisoquinoline alkaloids
HPLC-UV-MS-guided analysis of leaf samples of a botanically
yet undescribed Ancistrocladus liana from the Central Congoic naphthylisoquinolines from the leaves of an unexplored Congolese
d B2 (2) and the two newmbandakamines B3 (3) and B4 (4), which were
nd 7).
RSC Adv., 2019, 9, 12034–12046 | 12035
Fig. 2 Five known17,28–30 5,80- and 7,80-coupled naphthylisoquinoline
alkaloids isolated from the as yet unidentiﬁed Congolese Ancis-
trocladus liana: ancistrocongoline C (8), ancistrolikokines C (9) and F2
(10), and ealamines A (11) and G (12).
RSC Advances Paper
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View Article OnlineBasin, revealed the presence of secondary metabolites with UV
and MS proles typical of mono- and dimeric naph-
thylisoquinoline alkaloids. For the isolation of these
compounds, ground material of air-dried leaves was exhaus-
tively extracted with CH2Cl2–MeOH (1 : 1, v/v). The crude extract
was suspended in H2O, and, aer decantation and ltration, the
solid was dissolved in MeOH. Fractionation and purication of
the organic layer by reversed-phase HPLC provided six new
naphthylisoquinoline alkaloids, along with seven known
ones,4,6,16,17,28–30 which had already been isolated from other
Congolese Ancistrocladus species before.
One of the monomeric compounds was readily identied as
the 5,80-linked ancistrocongoline C (8) (Fig. 2). This alkaloid had
so far been known only from the Central African species A.
congolensis.28 It is the 40-O-methyl analog of the co-occurring
alkaloid ancistrolikokine C (9), previously detected as a main
constituent in the roots and twigs of A. likoko.17,29 These two N-
methylated naphthyltetrahydroisoquinoline alkaloids have now
been isolated along with ancistrolikokine F2 (10), which had
been found for the rst time in the twigs of A. likoko as one
further example of the very small group of 5,80-coupled naph-
thyldihydroisoquinolines with R-conguration at C-3.18
In addition, two known30 7,80-linked alkaloids were detected
in that unexplored Central African Ancistrocladus liana, viz.,
ealamines A (11) and G (12) (Fig. 2). They had previously been
discovered in the leaves and twigs of the Congolese liana A.
ealaensis.30 7,80-Coupled compounds with R-conguration at C-3
have been detected in Ancistrocladus plants only rarely.15,30–32 Up
to now, such an entity has been found in a total of just 13 (out of
over 250) naphthylisoquinoline alkaloids, among them four
dimers. Likewise noteworthy is the fact that these metabolites
have so far been identied only in two species, namely in A.
korupensis from Cameroon (three compounds)31,32 and in A.
ealaensis (ten representatives).15,3012036 | RSC Adv., 2019, 9, 12034–12046With their R-conguration at C-3 and an oxygen function at
C-6, these ve monomeric alkaloids 8–12 are typical ‘hybrid-
type’, i.e., mixed Ancistrocladaceae/Dioncophyllaceae-type
naphthylisoquinoline alkaloids.24 This nding is of special
interest from a geo- and chemotaxonomic point of view. The
metabolite proles of most of the Ancistrocladus plants from the
Northwestern Congo Basin are likewise dominated by the
presence of such hybrid-type alkaloids.4–7,14–18,28–30 Asian and
East African Ancistrocladaceae plants, by contrast, exclusively
produce 3S-congured and 6-oxygenated compounds (known as
‘Ancistrocladaceae-type’ alkaloids),22–25 whereas the only other
plant family that likewise contains naphthylisoquinolines, the
West African Dioncophyllaceae, solely forms alkaloids with R-
conguration at C-3, always lacking an oxygen function at C-6
(hence categorized as ‘Dioncophyllaceae-type’ alkaloids).24,25
Remarkably, from some of the species endemic to the Southern,
Central, and Eastern Congo, metabolites exclusively belonging
to the subclass of Ancistrocladaceae-type naphthylisoquinoline
alkaloids were isolated,9–11 whereas other species from these
regions mainly produce Dioncophyllaceae-type compounds,
along with a certain number of Ancistrocladaceae- and hybrid-
type alkaloids.8,20,21
Isolation work on the leaf extract of this phytochemically
unexplored Central Congolese Ancistrocladus liana also fur-
nished two known,4,6,16 constitutionally highly unsymmetric
dimers with a 60,100-coupled central biaryl axis, the mbandak-
amines A (1) and B2 (2) (Fig. 1). These structurally unusual
quateraryls had already been identied as constituents of the
above-mentioned as yet undescribed Congolese Ancistrocladus
liana from the rainforests in the Mbandaka region in the
Northwestern Congo Basin.4,6 Furthermore, only one further
species, A. ealaensis, was known to likewise produce
mbandakamine-type dimers, among them being mbandak-
amine A (1).16 This nding further supports the close chemo-
taxonomic relationship of that as yet unidentied Ancistrocladus
plant from the Ikela region in Central Africa to other Congolese
Ancistrocladus species, in particular to those indigenous to the
Northwestern part of the Democratic Republic of the Congo.
Furthermore, six new mono- and dimeric naph-
thylisoquinoline alkaloids were discovered in the leaves of that
Central Congolese Ancistrocladus liana.
The molecular formula of the rst new alkaloid, obtained as
a pale-yellow amorphous solid, was C50H56N2O8, as deduced
fromHRESIMS. It was, thus, identical to that of the co-occurring
dimer mbandakamine B2 (2). The
1H and 13C NMR data (Table
1) of the isolated compound were almost identical to those of 2,6
except for some slight shi diﬀerences, again showing a full set
of signals, which indicated that this new dimer was – similar to
2 – unsymmetric. The 1H NMR spectrum revealed the presence
of eight aromatic protons, two methylene groups with diaster-
eotopic protons, six methyl groups, two N-methyl functions, and
four aromatic O-methyl groups. The ‘southeastern’ half of the
new dimer displayed chemical shis typical of an N-methylated
naphthyltetrahydroisoquinoline with a 5,80-biaryl linkage. It
was established to be coupled via C-60 (dC 136.2) in the naph-
thalene subunit with a second, ‘northwestern’ part, whichThis journal is © The Royal Society of Chemistry 2019
Table 1 1H and 13C NMR data of mbandakamines B3 (3) and B4 (4) in methanol-d4 (150 MHz, d in ppm)
No.
3 4
dH (J in Hz) dC dH (J in Hz) dC
1/1000 4.68, q (6.6)/4.55, q (6.8) 58.9/58.1 4.70, q (6.7)/4.51, q (6.7) 49.0/59.0
3/3000 3.95, m/3.67, m 50.1/50.0 3.65, m/3.61, m 44.7/50.1
4ax=4
000
ax 1.74, dd (18.2, 11.2)/1.84, dd 32.2/29.3 1.75, dd (17.9, 11.4)/1.86, dd 33.4/29.3
(18.2, 11.8) (17.9, 5.1)
4eq=4
000
eq 2.77, dd (18.3, 4.5)/1.84, dd 2.84, dd (17.8, 4.7)/1.86, dd
(18.2, 5.1) (17.9, 11.5)
5/5000 119.5/123.0 119.7/122.9
6/6000 156.3/155.7 156.7/155.7
7/7000 6.65, s/5.64, s 97.9/98.3 6.66, s/5.63, s 98.0/98.3
8/8000 158.0/157.0 157.8/157.1
9/9000 115.6/112.4 114.8/112.3
10/10000 134.0/130.8 134.0/130.6
10/100 6.56, s/— 118.7/126.5 6.54, s/— 118.8/126.5
20/200 137.0/139.5 136.9/139.4
30/300 6.81, s/6.87, s 108.1/114.8 6.81, s/6.88, s 108.1/114.8
40/400 158.0/155.6 158.2/155.6
50/500 152.6/158.2 152.6/158.2
60/600 —/7.01, d (8.1) 136.2/104.8 —/7.02, d (8.0) 136.2/104.9
70/700 6.83, s/6.97, d (8.0) 132.8/132.8 6.83, s/6.97, d (8.0) 132.7/132.8
80/800 126.5/126.5 126.5/127.3
90/900 137.0/137.9 136.9/137.9
100/1000 115.6/115.9 115.6/115.9
1-CH3/1000-CH3 1.49, d (6.5)/1.42, d (6.7) 17.3/18.9 1.56, d (6.7)/1.42 (6.6) 18.7/18.9
3-CH3/3000-CH3 1.08, d (6.4)/1.08, d (6.4) 17.5/16.9 1.14, d (6.4)/1.08 (6.5) 19.2/16.9
N-CH3/N000-CH3 2.54, s/2.41, s 35.7/34.7 —/2.42, s —/34.6
8-OCH3/8000-OCH3 3.93, s/3.42, s 56.1/55.7 3.94, s/3.41, s 56.2/55.7
20-CH3/200-CH3 2.30, s/2.06, s 22.1/22.7 2.29, s/2.07, s 22.1/22.7
40-OCH3 4.06, s 57.0 4.06, s 57.0
500-OCH3 4.16, s 56.9 4.16, s 56.9
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View Article Onlinelikewise consisted of a naphthyl-1,3-dimethyl-N-methyltetrahy-
droisoquinoline of the 5,80-coupling type.
The rst, ‘southeastern’ molecular portion (Fig. 3B) was
found to possess four aromatic protons, with two singlets (dH
6.65 and 6.83) and a two-proton spin system in the naphthalene
part exhibiting a meta-coupling pattern (dH 6.56 and 6.81). In
the aliphatic region, it exhibited a quartet [H-1, (dH 4.68)],
a multiplet [H-3, (dH 3.95)], two diastereotopic protons, H-4ax (dH
1.74) and H-4eq (dH 2.77), and two O-methyl groups (dH 3.93 and
4.06). In that part of the 1H NMR spectrum, also two three-
proton doublets were monitored, typical of Me-1 (dH 1.49) and
Me-3 (dH 1.08), and two three-proton singlets, one correspond-
ing to an aryl-methyl group {Me-20, (dH 2.30)} in the naphthalene
part, and the other one evidencing the presence of an N-methyl
group (dH 2.54) in the isoquinoline subunit (Table 1). This
nding was conrmed by HMBC interactions of the methyl
protons with both, C-1 and C-3 (Fig. 3B). The location of the
biaryl linkage at C-80 was established from an HMBC cross peak
between H-10 (dH 6.56) and the quaternary carbon atom C-80 (dC
126.5). The attribution of H-10 was, in turn, corroborated by
a NOESY interaction with H-4ax and by the NOESY correlation
sequence {H-10 4 Me-20 4 H-30 4 OMe-40}. In the tetrahy-
droisoquinoline portion, the coupling position was deduced to
be C-5 (dC 119.5), as obvious from HMBC interactions from H-7
(dH 6.65), H-70 (dH 6.83), and H-4eq to C-5. The two methoxyThis journal is © The Royal Society of Chemistry 2019groups at dH 3.93 and 4.06 showed NOESY interactions with H-7
and H-30 (dH 6.81), respectively, thus being located at C-8 in the
isoquinoline subunit and at C-40 in the naphthalene part.
Consequently, the remaining two oxygen functions had to be
free hydroxy groups at C-6 and C-50 (Fig. 3B).
The 1H NMR spectrum (Table 1) of the northwestern
molecular portion again displayed the typical chemical shis of
a 5,80-coupled N-methylated naphthyltetrahydroisoquinoline
with a methoxy group (dH 3.42) at C-8000 (Fig. 3A). This was
conrmed by NOESY correlations in the series {H-7000 4 OMe-
8000 4 Me-1000 4 H-3000}, and by HMBC interactions from H-700
(dH 6.97), Heq-4000 (dH 1.84), and H-7000 (dH 5.64) to C-5000 (dC 123.0),
evidencing the coupling position of the biaryl axis in the iso-
quinoline subunit to be located at C-5000. In contrast to the
naphthalene part of the southeastern half, the signal pattern in
the 1H NMR spectrum showed an ortho coupling of the two
aromatic protons H-700 and H-600 (dH 7.01), no meta-coupled
doublets next to the high-eld shielded methyl group (dH 2.06)
at C-200, but only a singlet at H-300 (dH 6.87), thus suggesting C-100
and C-800 to be axis-bearing carbon atoms. ROESY correlations
between H-600 and MeO-500 (dH 4.16) revealed the naphthalene
unit of the northwestern naphthylisoquinoline to possess
a methoxy function at C-50. HMBC interactions from H-700 to C-
500 (dC 158.2) and C-900 (dC 137.9) and from H-600 to C-800 estab-
lished C-800 to be quaternary and, thus, proving that theRSC Adv., 2019, 9, 12034–12046 | 12037
Fig. 3 Selected 1H NMR data (in methanol-d4, d in ppm), HMBC (single orange arrows) and NOE (double blue arrows) interactions indicative of
the constitutions of the (A) ‘northwestern’ and (B) ‘southeastern’ naphthylisoquinoline portions of thembandakamines B3 (3) and B4 (4): the values
of 4 that are diﬀerent from those of 3 are given in {}. All other NMR data of 3 and 4 are nearly identical (0.02 ppm); (C) selected ROESY
correlations between the naphthalene subunit of the ‘northwestern’ half and the isoquinoline part of the ‘southeastern’ moiety establishing the
60,100-coupling sites in the central binaphthalene core (black arrows) and the relative conﬁguration at the centers and the two outer axes (blue
arrows) and at the central biaryl axis (red arrows) of 3 and 4; (D) conﬁrmation of the absolute conﬁguration of 3 and 4 at the central biaryl axis by
comparison of their ECD spectra with those of the known4,6,16 relatedmbandakamines A (1, central axis: P) and B2 (2, central axis:M): in the case of
3with the ECD curves of 1 (top) and 2 (center), and, in the case of 4, with the ECD spectrum of 2 (bottom); for the structures of 1 and 2, see Fig. 1.
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View Article Onlineisoquinoline and the naphthalene portions of the northwestern
molecular half were coupled through C-5000 and C-800 (Fig. 3A).
The proximity of a second aryl substituent to the methyl group
(dH 2.06) of the naphthalene subunit in the northwestern part of
the dimer became evident from the strongly upeld-shied
signal of Me-200, which revealed the central biaryl axis to
connect the two molecular halves of the isolated alkaloid by
a 60,100-coupling of the two naphthalene subunits. This assign-
ment was further proven by 3J HMBC interactions from H-300,
Me-200, and H-70 to C-100 (Fig. 3A and B), and from ROESY
interactions between H-10, Me-20, H-30, and MeO-40 in the
naphthalene unit of the northwestern naphthylisoquinoline
and OMe-8000 in the isoquinoline portion of the southeastern
half of the dimer (Fig. 3C). Thus, the central axis was located at
C-100, i.e., in the peri-position neighboring one of the outer axes
(i.e., C-800), which led to an extremely high steric hindrance
around that 60,100-linked central biaryl axis.
ROESY cross peaks of the protons of Me-1 (dH 1.49) to H-3 (dH
3.95), and of Me-1000 (dH 1.42) to H-3000 (dH 3.67) assigned the12038 | RSC Adv., 2019, 9, 12034–12046relative conguration of the methyl group at C-1 versus the one
at C-3, and that at C-1000 versus the one at C-3000, to be trans to each
other in both cases (Fig. 3C). The absolute congurations at C-3
and C-3000 in the two tetrahydroisoquinoline portions were
established by ruthenium-mediated oxidative degradation with
subsequent GC-MSD analysis of the resulting chiral products
according to a procedure developed by our group earlier.33 In
the case of the isolated alkaloid dimer, this analytical method
delivered only the R-enantiomers of 3-aminobutyric acid and of
N-methyl-3-aminobutyric acid (both derived from C-3), thus,
together with the relative trans-conguration assigned above,
the absolute congurations at C-3, C-3000, C-1, and C-1000 were
attributed to be all R. The congurations at the two outer axes in
the monomeric halves of the new dimer relative to the stereo-
centers became evident from specic long-range ROESY inter-
actions between H-10 and H-4ax and between H-70 and H-4eq in
the southeastern portion and between H-700 and H-4000eq in the
northwestern moiety (Fig. 3C). This, in combination with the
absolute congurations at C-1 and C-3 and at C-1000 and C-3000, asThis journal is © The Royal Society of Chemistry 2019
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View Article Onlineagain determined by the oxidative degradation, clearly showed
that the naphthalene–isoquinoline linkages both had to be P-
congured.
ROESY interactions were found across the central biaryl axis
between H-70 and Hax-4000 and between OMe-40 and H-7000
(Fig. 3C), which were identical to those earlier observed for
mbandakamine B2 (2),6 but complementary to those in mban-
dakamine A (1).4 These interactions established the central
biaryl axis of the new dimer to be M-congured.
This assignment was conrmed by the fact that the ECD
spectrum of the new metabolite was virtually identical to that of
the structurally closely related mbandakamine B2 (2) (Fig. 3D,
center), but nearly mirror-imaged to that of mbandakamine A
(1) (Fig. 3D, top), which is P-congured at the central biaryl axis.
Previous investigations4,8,16,21,34 had already revealed that the
chiroptical properties of such naphthylisoquinoline dimers are
dominated by the orientation of the two strong naphthalene
chromophores to each other, and, thus, by the conguration at
the central biaryl linkage, although – as in the case of 1 and the
new dimer – the stereoarrays at all the other six stereogenic
elements (two outer axes and four centers) were identical.
Consequently, the new mbandakamine-type dimer isolated
from the ‘new’ Central Congolese Ancistrocladus species had to
possess the full stereostructure 3, and – as displayed in Fig. 1 –
to be 1R,3R,5P,60M,5000P,3000R,1000R-congured. It was, hence, the
3-epi-analog of the co-occurring mbandakamine B2 (2).
According to its close structural relationship to 2, the new dimer
3 was given the name mbandakamine B3.
Resolution of a further alkaloid-enriched subfraction of the
leaf extract provided a second new dimeric naphthylisoquino-
line alkaloid. In 1H and 13C NMR analysis the compound
showed full sets of signals (Table 1) similar to those of 3, again
hinting at the presence of a mbandakamine-type dimer con-
sisting of two 5,80-coupled naphthyltetrahydroisoquinoline
halves connected to each other via C-60 and C-100. According to
HRESIMS, the new compound possessed a molecular formula
of C49H54N2O8, suggesting the presence of an O- or N-deme-
thylated derivative of 3. The 1D and 2D NMR data clearly
revealed the missing methyl group to be the one attached to the
nitrogen atom in the southeastern portion of mbandakamine B3
(3) (Table 1 and Fig. 3B), which was conrmed by the upeld
shis of C-1 (dC 49.0) and C-3 (dH 44.7) compared to those in 3
(dC 58.9 and 50.1, respectively).
By the above-employed methods – the oxidative degradation,
NMR investigations showing specic NOESY and ROESY inter-
actions across the two outer biaryl axes and between the iso-
quinoline subunit of the southeastern molecular half and the
naphthalene portion of the northwestern molecular moiety
(Fig. 3B), and ECD spectroscopy (Fig. 3C, bottom) – the new
dimer was assigned to be R-congured at all four stereogenic
centers, P-congured at the two outer axes, andM at the central
biaryl linkage, similar to mbandakamine B3 (3). Thus, this
second new dimer had the absolute stereostructure 4 as shown
in Fig. 1. It was henceforth named mbandakamine B4.
In addition to these twombandakamine-type dimers 3 and 4,
four new monomeric 5,80-coupled naphthylisoquinolines were
isolated from the leaf extract. According to the 1H and 13C NMRThis journal is © The Royal Society of Chemistry 2019data (Tables 2 and 3), these alkaloids showed a great constitu-
tional similarity, having in common a 40,50-dimethoxynaph-
thalene portion and an N-methyl function in their isoquinoline
halves, but clearly diﬀering by the OH/OMe substitution
patterns of their tetrahydroisoquinoline subunits, and by their
elements of central and axial chirality.
The rst new compound within this series of monomeric
alkaloids was obtained as a yellow amorphous solid. It corre-
sponded to amolecular formula of C25H29NO4, as deduced from
HRESIMS. Given a spin system of ve aromatic protons, with
three singlets (dH 6.50, 6.65, and 6.78) and two doublets due to
the presence of a pair of adjacent protons (dH 6.95 and 7.18) in
the naphthalene part (Fig. 4A), this substitution pattern hinted
either at a 60- or an 80-coupling site of the biaryl axis. HMBC
interactions from H-10 (dH 6.65) and H-60 (dH 6.95) to the
quaternary carbon atom C-80 (dC 126.6) in combination with
NOESY correlations in the series {H-10 4 Me-20 4 H-30 4
OMe-40} and a cross peak between H-60 and H-70 (dH 7.18) evi-
denced the tetrahydroisoquinoline moiety to be located at C-80
(Fig. 4A). The high-eld shied signals of the diastereotopic
protons at C-4 (dH 2.03 and 2.61) suggested the naphthalene half
to be located at C-5 of the isoquinoline part. This assignment
was conrmed by HMBC interactions of H-70, H-7 (dH 6.50), and
Heq-4 (dH 2.61) to C-5 (dC 119.7) (Fig. 4A). The
1H NMR spectrum
showed the chemical shis of two methoxy functions (d 3.93
and 3.95), which were attributed to be located at C-40 and C-50 in
the naphthalene subunit due to NOESY interactions to H-30 and
H-60, respectively. The two other oxygen functions thus had to
be free phenolic hydroxy groups at C-6 and C-8 in the iso-
quinoline part. From the 1H NMR signal at dH 2.72, corre-
sponding to three protons, and from the HMBC interactions of
this methyl group with both C-1 and C-3, it was evident that the
new compound was N-methylated.
From a NOESY correlation between H-3 (dH 3.96) and Me-1
(dH 1.72) (Fig. 4B, top), a relative trans-conguration of the
two stereocenters at C-1 and C-3 was established. The absolute
congurations, determined by ruthenium-mediated oxidative
degradation,33 were found to be R at both stereocenters. The
relative and, thus, absolute axial conguration was deduced to
be P, according to NOESY interactions between H-4ax (dH 2.03)
and H-10 on the one hand, and between H-4eq (dH 2.61) and H-70
on the other (Fig. 4B). The results were in agreement with the
ECD spectrum of the new metabolite, which was opposite to
that of the known28 (and co-occurring) 5,80-coupled, but M-
congured alkaloid ancistrocongoline C (8) (Fig. 4C, le). Thus,
the new compound possessed the stereostructure 5a as pre-
sented in Fig. 1. It was named ikelacongoline A, aer the Con-
golese town of Ikela, where the plant material had been
collected. This alkaloid may also be referred to as the N-meth-
ylated analog of korupensamine C from the Cameroonian liana
A. korupensis,26 or as the 50-O-methyl derivative of ancis-
trocongoline A,17,28 a main metabolite of both of the two Con-
golese species A. congolensis and A. likoko.
The second new monomeric alkaloid had the same molec-
ular formula of C25H29NO4 as ikelacongoline A (5a), which was
evidenced by HRESIMS measurements. It was again a 5,80-
linked N-methylated naphthyltetrahydroisoquinoline alkaloid,RSC Adv., 2019, 9, 12034–12046 | 12039
Table 2 1H NMR data of ikelacongolines A (5a), B (5b), C (6), and D (7) in methanol-d4 (600 MHz, d in ppm, J in Hz)
No. 5a 5b 6 7
1 4.72, q (6.7) 4.72, q (6.7) 4.65, q (6.6) 4.64, q (6.7)
3 3.96, m 3.92, m 3.15, m 3.23, m
4ax 2.03, dd (18.6, 11.9) 2.49, dd (18.6, 12.2) 2.58, dd (17.3, 11.5) 2.23, dd (17.3, 11.0)
4eq 2.61, dd (18.5, 4.9) 2.20, dd (18.8, 5.0) 2.21, dd (17.3, 2.9) 2.45, dd (17.3, 3.4)
7 6.50, s 6.48, s 6.60, s 6.62, s
10 6.65, s 6.77, s 6.69, s 6.73, s
30 6.78, s 6.79, s 6.80, s 6.79, s
60 6.95, d (8.0) 6.93, d (8.0) 6.94, d (8.0) 6.94, d (8.0)
70 7.18, d (7.9) 7.15, d (7.9) 7.16, d (7.9) 7.17, d (8.0)
1-CH3 1.72, d (6.7) 1.74, d (7.9) 1.73, d (6.6) 1.75, d (6.6)
3-CH3 1.24, d (6.6) 1.24, d (6.6) 1.27, d (6.5) 1.28, d (6.5)
N-CH3 2.72, s 2.77, s 3.02, s 3.01, s
8-OCH3 3.92, s 3.92, s
20-CH3 2.30, s 2.32, s 2.31, s 2.32, s
40-OCH3 3.93, s 3.93, s 3.93, s 3.93, s
50-OCH3 3.95, s 3.95, s 3.96, s 3.96, s
Table 3 13C NMR data of ikelacongolines A (5a), B (5b), C (6), and D (7)
in methanol-d4 (150 MHz, d in ppm)
No. 5a 5b 6 7
1 60.0 60.1 62.1 61.7
3 50.8 50.8 60.3 59.9
4 29.4 29.9 34.0 33.1
5 119.7 119.6 119.9 120.0
6 157.2 157.2 157.5 157.2
7 102.6 102.6 99.0 99.3
8 156.4 156.4 157.2 157.5
9 110.9 111.0 114.3 114.0
10 132.2 132.1 134.7 134.7
10 118.0 118.4 118.3 118.3
20 138.2 138.0 137.9 137.9
30 110.0 110.1 109.9 109.8
40 159.0 158.8 158.7 158.8
50 158.4 158.4 158.4 158.4
60 107.0 106.9 106.6 106.6
70 130.4 130.8 130.9 130.4
80 126.6 126.7 126.1 126.0
90 138.0 137.8 137.5 138.1
100 117.8 117.8 117.4 117.6
1-CH3 19.1 19.3 19.8 20.0
3-CH3 16.7 16.9 17.9 17.9
N-CH3 34.2 34.2 41.4 41.4
20-CH3 22.2 22.2 22.0 22.1
8-OCH3 56.1 56.1
40-OCH3 57.1 57.1 56.9 56.9
50-OCH3 56.9 56.9 56.7 56.7
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View Article Onlinewith 1H and 13C NMR data almost identical to those of 5a,
suggesting that the isolated compound possessed the same
constitution as 5a. Signicant diﬀerences in the NMR spectra of
these two alkaloids were monitored only for the chemical shis
of the diastereotopic protons Hax-4 (dH 2.49) and Heq-4 (dH 2.20)
(see Fig. 4A and Table 2) located next to the biaryl axis, thus
hinting at the presence of two probably atropo-diastereomeric
alkaloids in the leaves of this ‘new’ Ancistrocladus plant.
NOESY cross peaks of the protons of Me-1 (dH 1.74) to H-3 (dH
3.92) established the methyl groups at C-1 and C-3 to be trans to12040 | RSC Adv., 2019, 9, 12034–12046each other (Fig. 4B, bottom). The oxidative degradation proce-
dure again furnished only the R-enantiomers of 3-aminobutyric
acid and N-methyl-3-aminobutyric acid. In conjunction with the
relative trans-conguration, the absolute conguration of the
tetrahydroisoquinoline subunit had to be 1R,3R, similar as in
the case of 5a. Given the identical constitution and the same
congurations at C-1 and C-3, 5a and the new metabolite had to
diﬀer only by an opposite axial conguration. Long-range
NOESY correlations between Hax-4 and H-70 and between H-
4eq and H-10 (Fig. 4B, bottom) clearly revealed the new
compound to beM-congured at the biaryl linkage. This nding
was conrmed by the fact that the ECD spectrum was virtually
opposite to that of 5a, but nearly identical to that of the likewise
M-congured and 5,80-coupled ancistrocongoline C (8) (Fig. 4C,
le). Consequently, the new alkaloid possessed the stereo-
structure 5b and was hence the atropo-diastereomer of 5a. It
was named ikelacongoline B.
According to HRESIMS analysis, the third new alkaloid had
a molecular formula of C26H31NO4, thus possessing 14 mass
units more than 5a and 5b. Similar to the latter, the compound
again displayed NMR signals (see Tables 2 and 3) typical of anN-
methylated 5,80-coupled naphthyltetrahydroisoquinoline with
two methoxy groups in the naphthalene part (dH 3.93 and 3.96).
Unlike 5a and 5b, this alkaloid possessed a third methoxy
function (dH 3.92) at C-8 in the isoquinoline portion as deduced
from NOESY interactions between H-7 (dH 6.60) and OMe-8.
From an NOE correlation between H-1 (dH 4.65) and H-3 (dH
3.15) (Fig. 5A), the relative conguration at C-1 versus C-3 was
established to be cis. Ruthenium-mediated oxidative degrada-
tion yielded 3-aminobutyric acid and its N-methyl derivative as
their R-enantiomers, thus clearly establishing C-3 to be R-
congured. In view of the above-assigned cis-array of the two
methyl groups at C-1 and C-3, the absolute conguration of the
stereogenic center at C-1 was deduced to be S.
Based on the long-range NOESY interactions from H-4ax (dH
2.58) to H-70 (dH 7.16), and from H-10 (dH 6.69) to H-4eq (dH 2.21)
and H-3, the axial conguration was determined to be M
(Fig. 5A). The assignment was further corroborated by the factThis journal is © The Royal Society of Chemistry 2019
Fig. 4 (A) 1H NMR data (in methanol-d4, d in ppm), selected HMBC
(single orange arrows) and NOE interactions (double blue arrows) of
ikelacongolines A (5a) and B (5b): the values of 5b that are diﬀerent
from those of 5a are given in {}. All other values of 5a and 5b are nearly
identical (0.02 ppm); (B) NOESY correlations evidencing the relative
conﬁguration of 5a and 5b at the biaryl axis and at the stereogenic
centers C-1 and C-3 in the tetrahydroisoquinoline subunit; (C)
assignment of the absolute axial conﬁguration of 5a and 5b, by
comparison of their ECD spectra with that of the known,28 co-
occurring and structurally related alkaloid ancistrocongoline C (8); for
the structure of 8, see Fig. 1.
Fig. 5 NOESY interactions indicative of the conﬁguration at the biaryl
axis of (A) ikelacongoline C (6) and (B) ikelacongoline D (7) relative to
the stereogenic centers in the tetrahydroisoquinoline subunit.
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View Article Onlinethat the ECD spectrum of the isolated alkaloid matched the
ECD curves of the two related, likewise M-congured metabo-
lites ikelacongoline B (5b) and ancistrocongoline C (8) nearly
perfectly (see ESI†). This monomeric naphthylisoquinoline thus
possessed the absolute stereostructure 6, as presented in Fig. 1,
and, hence, was the new 1-epi analog of 8. It was named ikela-
congoline C.This journal is © The Royal Society of Chemistry 2019According to HRESIMS, the fourth isolated new metabo-
lite had the same molecular formula of C26H31NO4 as the
above-investigated ikelacongoline C (6). Moreover, 1D and 2D
NMR measurements hinted at a great structural similarity
with 6, indicating that the two alkaloids diﬀered only in the
stereochemical orientation of the methyl groups at C-1 and C-
3. The formation of S-N-methyl-3-aminobutyric acid by
oxidative degradation proved the new alkaloid to be S-
congured at C-3 (instead of R as assigned for 6). The relative
conguration of C-1 versus C-3 was again deduced to be cis,
due to a NOESY interaction of H-1 (dH 4.64) with H-3 (dH 3.23),
which was axial, as obvious from the coupling constants of
Hax-4 [dH 2.23, (1H, J ¼ 17.3, 11.0 Hz)] and Heq-4 [dH 2.45, (1H,
J ¼ 17.3, 3.4 Hz)]. Thus, given the relative cis-conguration at
C-1 and C-3, the absolute conguration at C-1 was deter-
mined to be R. On the basis of the resulting 1R,3S-stereoarray
in the tetrahydroisoquinoline part, the absolute axial
conguration was assigned to be M due to long-range NOE
cross peaks between H-70 (dH 7.17) in the naphthalene
subunit and Heq-4 in the isoquinoline portion, and also
between H-10 (dH 6.73) and Hax-4 (Fig. 5B). Comparison of the
ECD spectrum of the isolated alkaloid with that of 6, which
was similar (see ESI†), further conrmed this new metabolite
to possess the stereostructure 7, as shown in Fig. 1. The
compound was named ikelacongoline D. With its constitu-
tion being identical to that of ancistroyafungine A,9 an
alkaloid isolated earlier from a botanically likewise as yet
unidentied Ancistrocladus liana from the North-Central part
of the Congo Basin, and with the same conguration at C-1
and C-3, but with M-conguration at the biaryl axis, ikela-
congoline D might also be addressed as 5-epi-ancis-
troyafungine A.
The alkaloid pair 6/7 is most remarkable because their tet-
rahydroisoquinoline parts are enantiomeric to each other
(1S,3R versus 1R,3S), while the axes are identically congured.
The occurrence of such a pair of naphthylisoquinolines within
one plant is as yet unprecedented.RSC Adv., 2019, 9, 12034–12046 | 12041
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View Article OnlineAntiprotozoal activities of the mbandakamines B3 and B4 and
the ikelacongolines A–C
Parasitic diseases such as malaria, African sleeping sickness,
Chagas' disease, and leishmaniasis are still a major threat for
millions of people in tropical and developing countries and, as
a consequence, represent a serious obstacle to the social-
economic progress in aﬀected regions of Asia and Africa. The
dramatic increase of parasite resistance to routinely used
chemotherapeutics and the absence of vaccines aggravate the
situation dramatically.35–37 For this reason, several research
groups from medicinal chemistry, pharmacy, and infection
biology focus on the search of new eﬀective agents for the treat-
ment of tropical infectious diseases. In the recent years, intense
phytochemical studies on African plants have led to the discovery
of terpenoids, alkaloids, avonoids, quinones, lignans, couma-
rins, and many other natural products displaying excellent anti-
protozoal activities,38–45 thus providing templates and new
scaﬀolds for the development of a new generation of more potent
drugs. Most promising sources for such lead compounds are
Ancistrocladus species from Central Africa. Some of the
known4–6,8,10,11,15,16,20,21,25,28,29,46,47 mono- and dimeric naph-
thylisoquinolines exhibited pronounced inhibitory activities
against Plasmodium, Trypanosoma, and Leishmania parasites, thus
suggesting to likewise investigate the alkaloids of this Central
Congolese liana presented here for their biological potential.
The two newly discovered mbandakamine-type naph-
thylisoquinoline dimers 3 and 4 exhibited excellent activities in
vitro against both the chloroquine-sensitive (NF54) and the
chloroquine-resistant (K1) strain of the malaria parasite Plas-
modium falciparum, with half-maximum inhibition concentra-
tion values (IC50) of 39 nM (NF54) and even 6 nM (K1) for 3, and
66 nM (NF54) and 26 nM (K1) for 4 (Table 4). Thus, their anti-
plasmodial activities were comparable to those of the structur-
ally closely related – and likewise strongly active –
mbandakamine B2 (2),6 and were in the same order of magni-
tude as those of the standard agents chloroquine and artemi-
sinin (Table 4). Noteworthy was in particular the pronouncedTable 4 Antiparasitic activities of the mbandakamines B3 (3) and B4 (4)
falciparum (K1 and NF54 strains), Trypanosoma cruzi, Trypanosoma bruc
skeletal myoblast (L6) cells
Compound
IC50
a [mM]
P. falciparum
(K1 strain)
P. falciparum
(NF54 strain) T. cruzi
T. br
rhode
Standard 0.293c 0.009c 6.109e 0.03
0.010d 0.021d
2i 0.004i 0.017i 2.98i 0.00
3 0.006 0.039 15.1 0.47
4 0.026 0.066 19.7 0.21
5a 2.87 6.38 130 47.2
5b 2.75 8.10 72.2 15.3
6 1.41 4.51 92.9 15.1
a The IC50 values are themeans of two independent assays; the individual v
the ratio of the IC50 values concerning L6 cells to the IC50 data relative to P.
g Miltefosine. h Podophyllotoxin. i Values reported earlier, see ref. 6.
12042 | RSC Adv., 2019, 9, 12034–12046antiplasmodial activities of 2–4 especially against the
chloroquine-resistant K1 strain, without showing any cross-
resistance. The new mbandakamine B3 (3) was found to be
one of the most active naphthylisoquinolines against the
chloroquine-resistant strain K1 ever investigated. In addition,
given the comparatively low cytotoxicity of 3 (6.64 mM), this
dimer possessed a high selectivity index of ca. 1110. These
ndings made the mbandakamines B3 (3) and B4 (4) promising
candidates for further biological evaluations, also with respect
to the fact that they displayed good to strong activities against
the pathogen of African sleeping sickness, Trypanosoma brucei
rhodesiense, with IC50 values of 0.476 mM for 3 and 0.211 mM for
4 (Table 4). Their inhibitory potentials, however, were slightly
weaker than that of mbandakamine B2 (2), which showed
a pronounced eﬀect in vitro in the lower nanomolar range (IC50
¼ 5.0 nM),6 stronger than that of any other of the numerous
alkaloids tested so far.4–8,10,15,16,20,21,25,46,47
The inhibitory eﬀects of the new monomeric alkaloids ike-
lacongolines A (5a), B (5b), and C (6) against the strains NF54
and K1 of P. falciparum were drastically lower compared to those
of the dimers 2–4. For lack of material, ikelacongoline D (7) was
not tested. The compounds 5a, 5b, and 6 displayed only
moderate antiplasmodial activities, with micromolar IC50
values ranging from 1.41 to 8.10 (Table 4), and thus being 115 to
480 times less eﬀective than the mbandakamines 2–4.
These test results clearly demonstrated that the dimeric
architecture of the mbandakamines had a signicant impact on
the bioactivity of 5,80-linked naphthylisoquinoline alkaloids. A
similar eﬀect had previously also been observed for jozimine-
type naphthylisoquinoline dimers of natural8,21 and
synthetic48–50 origin consisting of two 7,10-coupled – far less
active – monomeric halves.
Against Leishmania donovani, the causative agent of visceral
leishmaniasis, only very weak or virtually no activities were
recorded for any of the investigated naphthylisoquinolines,
while for the pathogen of Chagas' disease, Trypanosoma cruzi,
a low, but unspecic inhibitory eﬀect (SI < 1) was observed for
the mbandakamines 2–4 (Table 4)., and the ikelacongolines A (5a), B (5b), and C (6) against Plasmodium
ei rhodesiense, and Leishmania donovani, and cytotoxicity against rat
ucei
siense L. donovani L6 cell (cytotoxicity)
Selectivity indexb
(K1/NF54)
0f 1.077g 0.0096h —/—b
5i 94.2i 1.37i 342/80.6
6 65.5 6.64 1107/170
1 59.5 6.68 257/101
>100 182 63.4/28.5
>100 60.5 22.0/7.47
>100 49.9 35.4/11.1
alues vary by a factor of less than 2. b The selectivity index is calculated as
falciparum. c Chloroquine. d Artemisinin. e Benznidazole. f Melarsoprol.
This journal is © The Royal Society of Chemistry 2019
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View Article OnlineExperimental
General experimental procedures
Optical rotations were determined on a Jasco P-1020 polarim-
eter operating with a sodium light source (l ¼ 589 nm). IR
spectra were recorded on a Jasco FT/IR-410 spectrometer, UV
spectra on a Shimadzu UV-1800 spectrophotometer, and ECD
measurements were performed on a Jasco J-715 spec-
tropolarimeter. The ECD data are reported in D3 values (cm2
mol1) at the given wavelength l (nm), they were processed
using SpecDis.51,52 NMR spectra (600 MHz for 1H and 150 MHz
for 13C) were taken on a Bruker DMX 600 instrument, using
methanol-d4, with the
1H or 13C signals of methanol (1H,
d 3.31 ppm, 13C, d 49.0 ppm) in the deuterated solvent as the
internal reference. Chemical shis (d) are reported in parts per
million (ppm), and coupling constants (J) are given in hertz
(Hz). NMR signal multiplicities are denoted as singlet (s),
doublet (d), doublet of doublets (dd), quartet (q), or multiplet
(m). Spectra were acquired and processed using the Topspin 3.5
soware (Bruker Daltonics). HRESIMS measurements were
performed in positive mode on a Bruker Daltonics micrOTOF-
focus mass instrument. GC-MSD was done on a GCMS-QP
2010SE System (Shimadzu). Preparative HPLC was carried out
on a Jasco System (PU-1580 Plus) in combination with UV/Vis
detection at 200–680 nm (Jasco MD-2010 Plus diode array
detector) at room temperature. For the isolation and purica-
tion of the constituents of the plant extracts, unless otherwise
stated, SymmetryPrep™ C18 column (19  300 mm, 7 mm,
Waters) was used, ow rate 10 mL min1; mobile phases: (A)
90% H2O with 10% MeCN (0.05% triuoroacetic acid) and (B)
90% MeCN with 10% H2O (0.05% triuoroacetic acid), using
linear gradients (details given below). All organic solvents were
of analytical-grade quality. Ultra-pure water was obtained from
an Elga Purelab Classic system. (S)-MTPA was purchased from
Sigma-Aldrich (Steinheim, Germany).Plant material
Leaves of the botanically as yet unidentied Ancistrocladus plant
were collected by one of us (V. M.) in July 2006, in the vicinity of
the village Leeke near the town of Ikela, Province Tshuapa,
Democratic Republic of the Congo. A voucher specimen (No.
114) has been deposited at the Herbarium Bringmann, Institute
of Organic Chemistry, University of Wu¨rzburg.Extraction and isolation
Air-dried leaves (ca. 300 g) were ground and exhaustively
extracted with CH2Cl2/MeOH (1 : 1, v/v) at room temperature.
The combined extracts were concentrated under reduced pres-
sure to give 22.1 g of a crude residue. The solid extract was
macerated in H2O, with mechanical shaking (160 rpm), then
ltered and dissolved in MeOH. Aer ltration, the raw meth-
anolic extract was directly subjected to preparative HPLC on
a SymmetryPrep™ C18 column, applying a linear gradient
(0 min 20% B, 28 min 45% B), nally providing 11 fractions (F1–
F11).This journal is © The Royal Society of Chemistry 2019Fractions F1 (3.1 mg) and F2 (4.2 mg) were resolved by
preparative HPLC, using an isocratic solvent system consisting
of the mobile phases A and B (16 : 84, v/v) to give pure ikela-
congoline B (5b) (2.7 mg) (retention time 25.4 min) and ikela-
congoline A (5a) (3.5 mg) (retention time 28.9 min). From
fraction F3 (2.6 mg), ealamine A (11) (1.7 mg) (retention time
18.9 min) was obtained, by isocratic HPLC using the solvents A
and B (80 : 20, v/v).
Fraction F5 (8.5 mg) was subjected to preparative HPLC on
a Chromolith SemiPrep RP-18e column (Merck, 10  100 mm)
applying a linear gradient (0 min 5% B, 6min 15% B, 9min 25%
B, 12 min 35% B, 15 min 45% B) at a ow rate of 5 mL min1,
aﬀording pure mbandakamine A (1) (2.1 mg) (retention time
10.4 min) and an alkaloid-containing subfraction, which was
further puried by preparative HPLC on a SymmetryPrep™ C18
column. Using an isocratic solvent system similar to the one
described above, but withMeOH instead of MeCN, consisting of
the solvents A0 and B0 (4.5 : 5 : 5, v/v), resolution of this sub-
fraction at a ow rate of 10 mL min1 furnished pure ikela-
congoline C (6) (4.9 mg) (retention time 11.9 min) and
ikelacongoline D (7) (1.3 mg) (retention time 14.0 min).
Purication of fraction F6 (9.1 mg) by preparative HPLC on
a Chromolith SemiPrep RP-18e column under the conditions
described above again yielded mbandakamine A (1) (3.6 mg)
(retention time 10.4 min) and, additionally, ancistrocongoline C
(8) (5.1 mg) (retention time 7.9 min).
From fractions F7 (8.7 mg) and F8 (8.3 mg), ealamine G (12)
and ancistrolikokine F2 (10) were isolated by preparative HPLC
on a Chromolith SemiPrep RP-18e column under the conditions
given above; the two compounds were further puried by semi-
preparative HPLC on a Waters XSelect HSS PFP column (10 
250 mm, 5 mm) using a mobile phase system consisting of the
solvents A0 and B0 under linear-gradient conditions (0 min 50%
B, 20 min 100% B) at a ow rate of 5 mL min1, thus nally
giving rise to pure 12 (1.5 mg) (retention time 7.9 min) and pure
10 (1.3 mg) (retention time 10.2 min).
Fraction F9 (8.1 mg) was resolved on a Chromolith SemiPrep
RP-18e column under the conditions described above,
furnishing pure ancistrolikokine C (9) (5.1 mg) (retention time
9.5min) andmbandakamine B4 (4) (3.0 mg) (retention time 11.2
min).
Resolution of fraction F10 (9.3 mg) by preparative HPLC on
a Chromolith SemiPrep RP-18e column, followed by chroma-
tography on a SymmetryPrep C18 column, using the solvent
systems A and B, with a linear gradient (0 min 20% B, 20 min
45% B), at a ow rate of 10 mL min1 gave pure mbandakamine
B3 (3) (3.8 mg) (retention time 18.9 min) and mbandakamine B2
(2) (5.1 mg) (retention time 19.4 min).
Mbandakamine B3 (3). Pale-yellow amorphous solid;
[a]25D 19.1 (c 0.08, MeOH); UV (MeOH) (log 3): lmax 226
(3.9) nm; ECD (c 0.1, MeOH) lmax (D3): 205 (3.0), 218 (+6.1), 233
(+2.9), 249 (3.9), 270 (0.3), 289 (1.0), 305 (2.1), 329 (0.4),
345 (0.7), and 376 (+0.1) nm; IR (ATR) nmax: 3357, 2923, 2851,
1976, 1672, 1598, 1418, 1313, 1256, 1200, 1132, 1076, 1039, 833,
800, and 720 cm1; 1H and 13C NMR data, see Table 1; HRE-
SIMS: m/z 813.4108 [M + H]+ (calcd for C50H57N2O8, 813.4114).RSC Adv., 2019, 9, 12034–12046 | 12043
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View Article OnlineMbandakamine B4 (4). Pale-yellow amorphous solid;
[a]25D 22.5 (c 0.09, MeOH); UV (MeOH) (log 3): lmax 229
(3.9) nm; ECD (c 0.1, MeOH) lmax (D3): 207 (6.7), 218 (+9.9), 235
(9.1), 240 (9.6), 246 (11.3), 271 (+1.6), 288 (2.1), 302
(1.8), 329 (0.7), 350 (1.8), 368 (+0.2), and 400 (+0.5) nm; IR
(ATR) nmax: 33 534, 2940, 2848, 2013, 1983, 1674, 1446, 1334,
1201, 1134, 838, 800, and 723 cm1; 1H and 13C NMR data, see
Table 1; HRESIMS:m/z 799.3957 [M + H]+ (calcd for C49H55N2O8,
799.3958).
Ikelacongoline A (5a). Yellow amorphous solid; [a]25D 11.5 (c
0.05, MeOH); UV (MeOH) (log 3): lmax 229 (3.5) nm; ECD (c 0.1,
MeOH) lmax (D3): 196 (+15.1), 211 (15.9), 217 (14.6), 223
(15.5), 238 (+7.2), 266 (+0.1), 280 (0.6), 300 (+0.1), 334 (0.4),
and 350 (0.1) nm; IR (ATR) nmax: 3373, 2943, 2015, 1673, 1604,
1585, 1524, 1490, 1456, 1434, 1392, 1298, 1264, 1201, 1137,
1091, 1041, and 722 cm1; 1H and 13C NMR data, see Tables 2
and 3;m/z 408.21699 [M + H]+ (calcd for C25H30NO4, 408.21748).
Ikelacongoline B (5b). Yellow amorphous solid; [a]25D 18.3 (c
0.05, MeOH); UV (MeOH) (log 3): lmax 230 (3.6) nm; ECD (c 0.1,
MeOH) lmax (D3): 198 (6.7), 211 (+11.1), 215 (+9.8), 224 (+6.5),
237 (8.8), 261 (+0.1), 284 (+1.7), 300 (+0.3), and 350 (0.2) nm;
IR (ATR) nmax: 3220, 2941, 2839, 1672, 1584, 1456, 1200, 1137,
837, 800, and 722 cm1; 1H and 13C NMR data, see Tables 2 and
3; HRESIMS: m/z 408.21747 [M + H]+ (calcd for C25H30NO4,
408.21748).
Ikelacongoline C (6). Brown amorphous solid; [a]25D 24.4 (c
0.05, MeOH); UV (MeOH) (log 3): lmax 231 (3.6) nm; ECD (c 0.1,
MeOH) lmax (D3): 196 (4.1), 210 (+12.4), 218 (+8.2), 222 (+8.6),
239 (12.4), 277 (0.3), 300 (+0.3), 318 (+0.5), and 351
(0.1) nm; IR (ATR) nmax: 3379, 2941, 2839, 1671, 1583, 1542,
1449, 1363, 1198, 1021, 832, 800, and 720 cm1; 1H and 13C
NMR data, see Tables 2 and 3; HRESIMS:m/z 422.23133 [M +H]+
(calcd for C26H32NO4, 422.23313).
Ikelacongoline D (7). Brown amorphous solid; [a]25D +44.3 (c
0.05, MeOH); UV (MeOH) (log 3): lmax 231 (3.6) nm; ECD (c 0.1,
MeOH) lmax (D3): 200 (15.5), 214 (+14.7), 227 (+31.8), 243
(11.2), 268 (+0.3), 285 (+0.9), 301 (0.7), and 310 (0.6) nm; IR
(ATR) nmax: 3415, 2927, 2851, 2273, 1674, 1585, 1437, 1204, 1137,
841, 802, and 724 cm1; 1H and 13C NMR data, see Tables 2 and
3; HRESIMS: m/z 422.23227 [M + H]+ (calcd for C26H32NO4,
422.23313).
Known alkaloids isolated
The likewise isolated known monomeric and dimeric naph-
thylisoquinoline alkaloids mbandakamines A (1) and B2 (2)
(Fig. 1), ancistrocongoline C (8), ancistrolikokine C (9), ancis-
trolikokine F2 (10), and ealamines A (11) and G (12) (Fig. 2), now
isolated for the rst time from the leaves of this as yet
unidentied Central Congolese Ancistrocladus liana, were found
to be identical in their spectroscopic, physical, and chromato-
graphic behavior with the data reported previously.4,6,16,17,28–30
Oxidative degradation
Following a procedure described earlier,33 ca. 0.8 mg of mban-
dakamines B3 (3) or B4 (4), or ikelacongolines A (5a), B (5b), C
(6), or D (7) were subjected to ruthenium(VIII)-catalyzed12044 | RSC Adv., 2019, 9, 12034–12046periodate oxidation, followed by conversion of the resulting
chiral amino with MeOH/HCl to the respective methyl esters
and Mosher-type derivatization with (R)-a-methoxy-a-tri-
uoromethylphenylacetyl chloride [(R)-MTPA-Cl, prepared from
(S)-MTPA]. The absolute congurations of 3, 4, 5a, 5b, 6, and 7 at
C-3 were assigned by gas chromatography coupled to mass-
selective detection (GC-MSD) and comparison with the corre-
sponding derivatives of the authentic amino acids of known
absolute conguration.Antiprotozoal assay
The in vitro antiparasitic activities of the mbandakamines B3 (3)
and B4 (4), and the ikelacongolines A (5a), B (5b), and C (6)
(Table 4) against the pathogens Plasmodium falciparum (NF54
and K1 strains), Trypanosoma cruzi (Tulahuen C4 strain, amas-
tigotes), Trypanosoma brucei rhodesiense (STIB 900 strain, try-
pomastigotes), and Leishmania donovani (MHOM-ET-67/L82,
amastigotes), and the cytotoxicity against mammalian host cells
(rat skeletal myoblast L6 cells) were determined as described
previously.53Conclusions
Prior to this work, mbandakamine-type naphthylisoquinoline
dimers4,16 had been known only from two Ancistrocladus species
indigenous to the Northwestern region of the Democratic
Republic of the Congo. The as yet unidentied liana on which
we report in this paper is the rst Ancistrocladus plant discov-
ered in the rainforests of the Central Congo Basin that was
found to produce such mbandakamine-type compounds, too.
From its leaves, four representatives were isolated, among them
two new dimers, the mbandakamines B3 (3) and B4 (4). They
were identied together with a series of four new 5,80-coupled
monomeric naphthylisoquinoline alkaloids, named ikela-
congolines A–D (5a, 5b, 6, and 7), and along with ve alkaloids
(8–12) known from previous phytochemical studies on related
Congolese Ancistrocladus species;17,28–30 three of them likewise
belonged to the subclass of 5,80-linked alkaloids, whereas two
compounds were representatives of the quite rare 7,80-coupling
type. Particularly striking was the considerable number of N-
methylated naphthylisoquinolines in this botanically and
phytochemically so far unexplored plant, among them the two
new mbandakamines B3 (3) and B4 (4) and the four new
monomeric ikelacongolines A–D. More than half of the
metabolites isolated from the leaf extract showed the presence
of such an N-methyl group. The structures of these mono- and
dimeric naphthylisoquinolines are chemotaxonomically quite
signicant, indicating a close phylogenetic relationship of this
Ancistrocladus plant to other Ancistrocladus species from the
Congo Basin, in particular to A. ealaensis15,16,30 and another yet
unidentied Ancistrocladus taxon4–6 from the Northwestern part
of the Democratic Republic of the Congo. These two species are
likewise known to produce a high number of 5,80-linked
monomeric alkaloids along with mbandakamine-type dimers.
Similar to the Ancistrocladus species presented here, their
metabolite proles are also dominated by the presence of mixedThis journal is © The Royal Society of Chemistry 2019
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View Article OnlineAncistrocladaceae/Dioncophyllaceae, i.e., hybrid-type alkaloids,
i.e., with R-conguration at C-3 and an oxygen function at C-6.
Furthermore, the new mbandakamines 3 and 4 have proven
to be potent bioactive compounds displaying good to strong
inhibitory eﬀects against the pathogen of African sleeping
sickness, Trypanosoma brucei rhodesiense, and, in particular,
exerting excellent activities against chloroquine-sensitive
(NF54) and chloroquine-resistant (K1) strains of the malaria
parasite Plasmodium falciparum. With respect to the fact that the
eﬃciency of many recommended therapeutic agents routinely
used for the treatment of infectious diseases is threatened by
the formation of an increasing resistance, the discovery of new
agents is urgently needed. The promising activities of
mbandakamine-type dimers warrant further investigations on
their antiparasitic potential in particular, and on that of mono-
and dimeric naphthylisoquinoline alkaloids in general. This
work is in progress.Conﬂicts of interest
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